What is dose response, and what's a dose response model? | Andrew Maynard

  Рет қаралды 58,358

Risk Bites

Risk Bites

Күн бұрын

Пікірлер: 15
@mariasaraiva9675
@mariasaraiva9675 11 жыл бұрын
This came in time for my students. They asked me to explain dose-response last lecture. And here we go together with the models too , begining this week.
@riskbites
@riskbites 11 жыл бұрын
Perfect timing :-)
@OAlem
@OAlem 4 жыл бұрын
This is perfect and so is the other video about models! I'm compiling a top ten video of scientific models and this is compelling. It should at least get an honorary mention but I honestly hadn't thought of this one. Can I have your permission to use small bits of these two videos? I'm still compiling my list and expect to release it in the next few days. I will provide links to your originals if you like.
@BusManTravelGroupGMBH
@BusManTravelGroupGMBH 6 ай бұрын
Also . Car accidents are caused by Speed. DUIs proportionate. These are known as Independent Variables. However correlation does not always equate to causation
@ahmedabuali6768
@ahmedabuali6768 3 жыл бұрын
Dear Professor, I am trying to implement the work done by Suyu Liu, “A Bayesian Phase I/II Trial Design for Immunotherapy”, using R, since the code attached with that work takes a lot of time (more than 20 hours and the code not complete, I do not know how it produced the tables and the figures). So that I tried to use trialr package trying to get similar or approximate results using the utility functions for sensitivity analysis in table 1 (picture below), but this package allowed me to use just two outcomes ( toxicity, efficacy ) and the work of Liu used three outcomes (immune response, toxicity, and efficacy). I want to see if I used the correct utility (table 1 below) and to see how to add a third outcome ( immune response ) to the model? (Question 1) I attached to you the code and the output for 50 iterations and 60 patients from the work of Liu and Yuan ( I cannot do more, it took around 12 hours), if you know how he produced the results, (Question 2) I hope you can feed me back. My goal is: to use their idea to select the best dose in the first stage and to continue in a second stage with only 2 arms clinical trial and the best dose. (may there is another way to do that?) Table 1 ### My code trying to get similar results using trialr package ### rm(list = ls()) library(trialr) ## Utility from table 1 and Liu and Yuan work. Uti
@ahmedabuali6768
@ahmedabuali6768 3 жыл бұрын
Hi, I have a problem to simulate a scenario in clinical trial phase I/II, with R, where I can ask people to help me even for paid consultancy?
@xrhsavgh
@xrhsavgh 5 жыл бұрын
Thank you 🙏🏽🙏🏽🙏🏽
@alinashahid2744
@alinashahid2744 3 жыл бұрын
MSPH 🙌
@es5248
@es5248 4 жыл бұрын
I couldn’t get past the guitar and focus.
@binra3788
@binra3788 Жыл бұрын
Risk models offer trojan for fear, funding and controls to operate a self replicating and reinforcing loop by which 'defenceses or protections are not only destructive but recognised and used as such by private interests controlling 'regulators'. Insurance is a casino based an odds arrived at from data set into models. Predictive models become repurposed to predictive control. Control of a model or massaged and shaped data can and does operate backstage as the use of regulations to crush rivals, or defend against litigation or critical reevaluation. Especially once 'settled science' is protected as 'too big to fail'.
@Mentocthemindtaker
@Mentocthemindtaker 5 жыл бұрын
But...but...hormesis says that consistent low dose exposure _strengthens_ my cells and _decreases_ my risk of getting something like cancer. That's why every morning I slap on a low-dose fentanyl patch, suck on a lead-paint chip and make sure at least one item of my breakfast has just a little bit of E. coli "contamination". As a result I feel confident enough to take on anything that the world can throw at me!
@riskbites
@riskbites 5 жыл бұрын
... and I'm sure your body will rise to the challenge magnificently for as long as it lasts, which may not be as long as you might hope :)
@Mentocthemindtaker
@Mentocthemindtaker 5 жыл бұрын
@@riskbites Thanks! Hopefully the SARI lobbyists and members on the EPA get their way and reduce the safety requirements for worker's radiation exposure limits. Then I can get a job doing nuclear clean-up (they're always recruiting) so I can get _even stronger_ through radiation exposure! Life sure does look good!
@chummychimchim
@chummychimchim 4 жыл бұрын
Lmao!
@binra3788
@binra3788 Жыл бұрын
If you want a disease to prove you right you are more than capable of manifesting it. Living life is key to adaptive capacity. You are in any case exposed to or imbibing similar toxins some by choice and some as unavoidable environmental exposures. Devious people can and do manipulate selected fears (real or imagined) to generate narratives, funding, and control over others. But not least because of attitudes like your sarcasm reveal, people trust their abusers, and actively seek toxic or destructive outcomes as belief they are 'made safe'. I think it depends. BTW. Some heavy metals are cumulative and not easily eliminated - especially if injected. But the LNT for radiation has been shown to be false.
MedPhys - 25.2 - Radiation Protection: Risk models, dose limits and monitoring.
9:01
Medical Physics, Radiation Oncology & Cancer
Рет қаралды 220
How it feels when u walk through first class
00:52
Adam W
Рет қаралды 26 МЛН
This dad wins Halloween! 🎃💀
01:00
Justin Flom
Рет қаралды 27 МЛН
НИКИТА ПОДСТАВИЛ ДЖОНИ 😡
01:00
HOOOTDOGS
Рет қаралды 2,9 МЛН
The naked truth about scientific models
3:12
Risk Bites
Рет қаралды 37 М.
RAD 211. - Radiation effects
57:42
Rock The Registry
Рет қаралды 4,8 М.
Benchmark Dose modelling for the safety assessment of Novel Foods
2:22
ISO 27001 Risk Assessment: The Ultimate Guide
16:50
URM Consulting
Рет қаралды 60 М.
Risk management basics: What exactly is it?
4:26
RiskDoctorVideo
Рет қаралды 501 М.
Dose Area Product DAP, Kerma Area Product KAP
8:33
How Radiology Works
Рет қаралды 2,9 М.
Radiation units: Absorbed, Equivalent & Effective dose
7:05
Dr. Paulien Moyaert
Рет қаралды 82 М.
Linear No-Threshold (LNT) Model: Explained!
5:25
Sahand Hooshmand
Рет қаралды 931
An Introduction to Surveillance - The Eyes and Ears of Public Health
8:15
Let's Learn Public Health
Рет қаралды 357 М.
How it feels when u walk through first class
00:52
Adam W
Рет қаралды 26 МЛН